(5E)-2-mercapto-5-(2-methoxybenzylidene)-1,3-thiazol-4(5H)-one, 95.0%, 5g

6-(TRIFLUOROMETHYL)ISOQUINOLINE-1-CARBOXYLIC ACID, 95%, 100mg

5-Bromo-6-methoxyindoline-2,3-dione, 98%, 500mg

Dasatinib, 95.0%, 10g

4-(Piperazin-1-yl)butan-2-one hydrochloride, 98%, 1g

N-(5-Methyl-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-imidazol-2-amine, 98%, 10mg

N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(methylsulfonamido)cyclohexyl)oxalamide (Edoxaban Impurity), 98%, 50mg

4-Chloro-2-ethoxybenzoic acid, 95%, 500mg

2-(Dicyclohexylphosphino)-3,6-dimethoxy-2'-4'-6'-tri-i-propyl-1,1'-biphenyl, 98.0%, 10g

7-Fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 250mg

Sample beakers with screw closure without graduation, without labelling area, 30 ml, Non-sterile, 1000 Piece(s)

Methyl 5-chloro-1H-indole-7-carboxylate, 98+%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g